Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study to Evaluate Helicobacter Pylori Eradication at the End of Routine Triple Eradication Therapy With Duodenal Ulcer Relapses Control.

NCT01199536 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01199536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01199536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study to Evaluate Helicobacter Pylori Eradication at the End of Routine Triple Eradication Therapy With Duodenal Ulcer Relapses Control.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
November 30, 2013
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

duodenal ulcer